Efficacy Against Variants Being Tested News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Efficacy against variants being tested. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Efficacy Against Variants Being Tested Today - Breaking & Trending Today

250 Million Sputnik Doses For India in 8-10 Months, Efficacy Against Variants Being Tested: Dr Reddy's Executive

250 Million Sputnik Doses For India in 8-10 Months, Efficacy Against Variants Being Tested: Dr Reddy s Executive
News18
2 hours ago
Marya Shakil
© Provided by News18
250 Million Sputnik Doses For India in 8-10 Months, Efficacy Against Variants Being Tested: Dr Reddy s Executive
India will receive a total of 250 million doses of Russia’s Sputnik V over the next 8-10 months and its production here is expected to begin from July, a top executive at Dr Reddy’s, the local partner for the vaccine against Covid-19, said on Friday. The vaccine by Russia’s Gamaleya Institute is priced at Rs 948; its retail price of Sputnik V will be Rs 995.40 a dose with 5% GST. “The price which has been announced is Rs 948 plus GST for the imported dosages. Once we have the India-manufactured product available, the pricing for the vaccine will be different. We do not have a figure currently. We are working out the best possible ways to minimise the num ....

South Africa , Andhra Pradesh , United Kingdom , South African , Deepak Sapra , Serum Institute Covishield , Gamaleya Institute Of Epidemiology , National Institute Of Virology , Central Drugs Laboratory , Russia Gamaleya Institute , Services At Dr Reddy , Russian Direct Investment Fund , Sputnik Doses For India , Efficacy Against Variants Being Tested , Gamaleya Institute , National Institute , Central Drugs , Bharat Biotech , Serum Institute , Sputnik Light , ஆந்திரா பிரதேஷ் , ஒன்றுபட்டது கிஂக்டம் , தீபக் சப்ரா , தேசிய நிறுவனம் ஆஃப் வைராலஜி , மைய மருந்துகள் ஆய்வகம் , ரஷ்ய நேரடி முதலீடு நிதி ,

250 Million Sputnik Doses For India in 8-10 Months, Efficacy Against Variants Being Tested: Dr Reddy's Official

Dr Reddy's Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Sapra taking the first shot in Hyderabad. ....

South Africa , Andhra Pradesh , United Kingdom , South African , Deepak Sapra , Serum Institute Covishield , Services At Dr , Gamaleya Institute Of Epidemiology , National Institute Of Virology , Central Drugs Laboratory , Russia Gamaleya Institute , Russian Direct Investment Fund , Sputnik Doses For India , Efficacy Against Variants Being Tested , Gamaleya Institute , National Institute , Central Drugs , Bharat Biotech , Serum Institute , Sputnik Light , ஆந்திரா பிரதேஷ் , ஒன்றுபட்டது கிஂக்டம் , தீபக் சப்ரா , தேசிய நிறுவனம் ஆஃப் வைராலஜி , மைய மருந்துகள் ஆய்வகம் , ரஷ்ய நேரடி முதலீடு நிதி ,

India to Get 250 Million Sputnik V Doses in 8-10 Months, Efficacy Against Variants Being Tested: Dr Reddy's

250 Million Sputnik Doses For India in 8-10 Months, Says Dr Reddy s Executive
Marya Shakil
© Provided by News18
250 Million Sputnik Doses For India in 8-10 Months, Says Dr Reddy s Executive
India will receive a total of 250 million doses of Russia’s Sputnik V over the next 8-10 months and its production here is expected to begin from July, a top executive at Dr Reddy’s, the local partner for the vaccine against Covid-19, said on Friday. The vaccine by Russia’s Gamaleya Institute is priced at Rs 948; its retail price of Sputnik V will be Rs 995.40 a dose with 5% GST. “The price which has been announced is Rs 948 plus GST for the imported dosages. Once we have the India-manufactured product available, the pricing for the vaccine will be different. We do not have a figure currently. We are working out the best possible ways to minimise the number so that it is accessible to as many Indians as possible,” Deepak Sapra, CEO, API & Services a ....

South Africa , Andhra Pradesh , United Kingdom , South African , Deepak Sapra , Serum Institute Covishield , Services At Dr , Gamaleya Institute Of Epidemiology , National Institute Of Virology , Central Drugs Laboratory , Russia Gamaleya Institute , Russian Direct Investment Fund , Sputnikv Doses , Efficacy Against Variants Being Tested , Gamaleya Institute , National Institute , Central Drugs , Bharat Biotech , Serum Institute , Sputnik Light , ஆந்திரா பிரதேஷ் , ஒன்றுபட்டது கிஂக்டம் , தீபக் சப்ரா , தேசிய நிறுவனம் ஆஃப் வைராலஜி , மைய மருந்துகள் ஆய்வகம் , ரஷ்ய நேரடி முதலீடு நிதி ,